Bendamustine, Bortezomib and Dexamethasone (BBD) As First-Line Treatment Of Patients (Pts) With Multiple Myeloma Who Are Not Candidates For High Dose Chemotherapy
Year: 2013
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Jesus Berdeja, Michael Savona, Luis Chu, James Essell, Patrick Murphy, Todd Bauer, Eric Raefsky, Ralph V. Boccia, Ian Flinn
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4244039656
